Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.59 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.59 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.58 |
| ▸ | TFPI | P10646 | 2/20 | 0.57 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.57 |
| ▸ | CALCR | P30988 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30648455 | 0.98 | EP300 (0.64) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL30277959 | 0.98 | KEAP1 (0.60) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL29479812 | 0.96 | KEAP1 (0.60) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL31000870 | 0.91 | MAPK8 (0.67) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL30262198 | 0.89 | EP300 (0.64) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL29562124 | 0.89 | NPY2R (0.67) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL30432659 | 0.88 | EP300 (0.69) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL30648475 | 0.88 | GLP1R (0.61) | TFPI | |
| SCHEMBL31182641 | 0.88 | MAPK8 (0.63) | EP300HIF1ANMUR2NMUR1NPY2R | |
| SCHEMBL30432021 | 0.88 | NPY2R (0.68) | EP300HIF1ANPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630447-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | Abwiz Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20240352445-A1 | HUMANIZATION, AFFINITY MATURATION, AND OPTIMIZATION METHODS FOR PROTEINS AND ANTIBODIES | ABWIZ BIO, INC. | 2024-10-24 | — | — | US | disclosed |
| WO-2024124241-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | ABWIZ BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2023019019-A2 | HUMANIZATION, AFFINITY MATURATION, AND OPTIMIZATION METHODS FOR PROTEINS AND ANTIBODIES | ABWIZ BIO, INC. (US) | 2023-02-16 | — | — | WO | disclosed |